Shares of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) experienced a sharp increase after a significant regulatory victory in the UK. SNOA stock was up 63.94% at
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares were rising 11.90% to $3.95 as of this morning’s last pre-market check. SNOA has made a number of encouraging
The value Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares are increasing significantly today, indicating that the market has responded favorably to the company’s switch to a
Sonoma Pharmaceuticals, Inc. (SNOA) stock prices were down 18.88% some time after market trading commenced on July 15th, 2021, bringing the price per share down
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) shares hiked 32.30% to reach $8.11 in the pre-market session after the announcement that they have reached a license and
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a multinational healthcare giant, has released financial results for its second fiscal quarter and six months ended September 30, 2020,
The equity markets have regained upside momentum this afternoon. This follows the Fed’s decision to keep supporting the markets. A statement from the FOMC said
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.